ADVA news and filing
ADVANCED MEDICAL PRODUCTS INC (ADVA)
Quarterly Report (SEC form 10QSB)
MANAGEMENTS DISCUSSION AND ANALYSIS
Forward Looking Statements This and other sections of this report contain "forward- looking statements" within the meaning of the Private Securities Litigation
Reform Act of 1995, which represent the Company's expectations concerning future events, including whether changes in the Company's Certificate of Incorporation
will occur, or that the market price of the Common Stock immediately after implementation of the proposed Reverse Stock Split will be maintained for any period of
time, or that such market price will approximate ten times the market price before the proposed Reverse Stock Split, or that a suitable reverse merger partner can be
timely located, or that a suitable reverse merger transaction can be successfully negotiated or completed. By their very nature, forward- looking statements are
subject to known and unknown risks and uncertainties relating to the Company's and other parties' future performance that may cause actual results to differ
materially from those expressed or implied in such forward- looking statements. The Company does not undertake and assumes no obligation to update any
forward-looking statement that may be made herein or from time to time by or on behalf of the Company.
The following discussion should be read in conjunction with the accompanying Financial Statements, including the notes thereto, appearing elsewhere herein.
Results of Operations The Company has ceased operations and had no operations and no sales for the three months or six months ended December 31, 1999.
There were no selling, general and administrative expenses and no research and development costs, and there was no profit or loss.
The Company's gross profit margin for the three months ended December 31, 1998 was 39 % of net sales. Selling, general and administrative expenses, not
including bad debt writeoffs, for the three months ended December 31, 1998 were 59.3% of net sales.
Research and development costs for the quarter ended December 31, 1998 were 6.3% of sales.
Net loss applicable to common shares for the quarter ended December 31, 1998 was $0.06.
During the first three months ended December 31, 1999, cash decreased by $62,918 and liabilities decreased by $62,918 as administrative expenses and priority
claims were paid by the debtor in possession.
Liquidity and Capital Resources The Company ceased operations on May 11, 1999. The cash available on December 31, 1999 of $1,155 was insufficient to meet
remaining priority claims totaling approximately $ 24,030. No capital resources are presently available to the Company, and there is no liquidity.
|
